Clinical Trial Update: Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ipilimumab with carboplatin and paclitaxel in patients with untreated unresectable stage III or stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Jewish General Hospital | Conditions: Untreated Stage III Melanoma or Stage IV Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING